- Home
- CMPX vs HYB Comparison
CMPX vs HYB Comparison
Compare CMPX & HYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- HYB
- Stock Information
- Founded
- CMPX 2014
- HYB 1987
- Country
- CMPX United States
- HYB United States
- Employees
- CMPX N/A
- HYB N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- HYB Investment Managers
- Sector
- CMPX Health Care
- HYB Finance
- Exchange
- CMPX Nasdaq
- HYB Nasdaq
- Market Cap
- CMPX 214.6M
- HYB 191.2M
- IPO Year
- CMPX N/A
- HYB 1999
- Fundamental
- Price
- CMPX $2.00
- HYB $8.23
- Analyst Decision
- CMPX Strong Buy
- HYB
- Analyst Count
- CMPX 4
- HYB 0
- Target Price
- CMPX $13.75
- HYB N/A
- AVG Volume (30 Days)
- CMPX 1.8M
- HYB 39.6K
- Earning Date
- CMPX 11-12-2024
- HYB 01-01-0001
- Dividend Yield
- CMPX N/A
- HYB 6.67%
- EPS Growth
- CMPX N/A
- HYB N/A
- EPS
- CMPX N/A
- HYB N/A
- Revenue
- CMPX $850,000.00
- HYB N/A
- Revenue This Year
- CMPX N/A
- HYB N/A
- Revenue Next Year
- CMPX $613.39
- HYB N/A
- P/E Ratio
- CMPX N/A
- HYB N/A
- Revenue Growth
- CMPX N/A
- HYB N/A
- 52 Week Low
- CMPX $0.77
- HYB $6.23
- 52 Week High
- CMPX $2.68
- HYB $7.41
- Technical
- Relative Strength Index (RSI)
- CMPX 65.48
- HYB 51.78
- Support Level
- CMPX $1.43
- HYB $8.14
- Resistance Level
- CMPX $2.68
- HYB $8.29
- Average True Range (ATR)
- CMPX 0.24
- HYB 0.07
- MACD
- CMPX 0.06
- HYB 0.01
- Stochastic Oscillator
- CMPX 46.87
- HYB 66.67
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About HYB New America High Income Fund Inc. (The)
New America High Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide high current income while seeking to preserve stockholder capital by investing in a diversified portfolio of high-yield fixed-income securities. The Fund has a leveraged capital structure. The fund invests in fixed-maturity corporate debt securities that are rated less than the investment grade. Its portfolio of investment consists of investments in different sectors such as energy, financial, cable operators, healthcare, and others.